175 related articles for article (PubMed ID: 10520784)
1. Thrombin generation after the abrupt cessation of intravenous unfractionated heparin among patients with acute coronary syndromes: potential mechanisms for heightened prothrombotic potential.
Becker RC; Spencer FA; Li Y; Ball SP; Ma Y; Hurley T; Hebert J
J Am Coll Cardiol; 1999 Oct; 34(4):1020-7. PubMed ID: 10520784
[TBL] [Abstract][Full Text] [Related]
2. Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes.
Granger CB; Miller JM; Bovill EG; Gruber A; Tracy RP; Krucoff MW; Green C; Berrios E; Harrington RA; Ohman EM
Circulation; 1995 Apr; 91(7):1929-35. PubMed ID: 7895349
[TBL] [Abstract][Full Text] [Related]
3. Activated partial thromboplastin time and clinical outcome after thrombin inhibition in unstable coronary artery disease.
Oldgren J; Linder R; Grip L; Siegbahn A; Wallentin L
Eur Heart J; 1999 Nov; 20(22):1657-66. PubMed ID: 10543929
[TBL] [Abstract][Full Text] [Related]
4. Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation.
Salvioni A; Casilli F; Assanelli E; Grazi M; Marenzi G; Guazzi MD
Thromb Haemost; 2001 Oct; 86(4):991-4. PubMed ID: 11686357
[TBL] [Abstract][Full Text] [Related]
5. Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris.
Hafner G; Rupprecht HJ; Luz M; Terres W; Schindel F; Friesen HJ; Heinrichs H; Jessel A; Meyer J; Prellwitz W
Eur Heart J; 1996 Aug; 17(8):1207-15. PubMed ID: 8869862
[TBL] [Abstract][Full Text] [Related]
6. Rebound thrombin generation after heparin therapy in unstable angina. A randomized comparison between unfractionated and low-molecular-weight heparin.
Bijsterveld NR; Moons AH; Meijers JC; Tijssen JG; Büller HR; Levi M; Peters RJ
J Am Coll Cardiol; 2002 Mar; 39(5):811-7. PubMed ID: 11869846
[TBL] [Abstract][Full Text] [Related]
7. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
[TBL] [Abstract][Full Text] [Related]
8. Thrombin formation and effect of unfractionated heparin during pediatric cardiac catheterization.
Chen D; Långström S; Petäjä J; Heikinheimo M; Pihkala J
Catheter Cardiovasc Interv; 2013 Jun; 81(7):1174-9. PubMed ID: 22915548
[TBL] [Abstract][Full Text] [Related]
9. The effect of a low molecular mass thrombin inhibitor, inogatran, and heparin on thrombin generation and fibrin turnover in patients with unstable coronary artery disease.
Linder R; Oldgren J; Egberg N; Grip L; Larson G; Siegbahn A; Wallentin L
Eur Heart J; 1999 Apr; 20(7):506-18. PubMed ID: 10365287
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris.
Gold HK; Torres FW; Garabedian HD; Werner W; Jang IK; Khan A; Hagstrom JN; Yasuda T; Leinbach RC; Newell JB
J Am Coll Cardiol; 1993 Apr; 21(5):1039-47. PubMed ID: 8459055
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of unfractionated heparin and low molecular weight heparin on vascular endothelial cell tissue factor pathway inhibitor release: a model for assessing intrinsic thromboresistance.
Li Y; Rodriquez M; Spencer FA; Becker RC
J Thromb Thrombolysis; 2002 Oct; 14(2):123-9. PubMed ID: 12714831
[TBL] [Abstract][Full Text] [Related]
12. Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes.
Magee KD; Sevcik W; Moher D; Rowe BH
Cochrane Database Syst Rev; 2003; (1):CD002132. PubMed ID: 12535430
[TBL] [Abstract][Full Text] [Related]
13. Transient thrombotic state after abrupt discontinuation of heparin in percutaneous coronary angioplasty.
Smith AJ; Holt RE; Fitzpatrick JB; Palacios IF; Gold HK; Werner W; Bovill EG; Fuster V; Jang IK
Am Heart J; 1996 Mar; 131(3):434-9. PubMed ID: 8604621
[TBL] [Abstract][Full Text] [Related]
14. New heparin dosing recommendations for patients with acute coronary syndromes.
Menon V; Berkowitz SD; Antman EM; Fuchs RM; Hochman JS
Am J Med; 2001 Jun; 110(8):641-50. PubMed ID: 11382373
[TBL] [Abstract][Full Text] [Related]
15. Higher Maximum Doses and Infusion Rates Compared with Standard Unfractionated Heparin Therapy Are Associated with Adequate Anticoagulation without Increased Bleeding in Both Obese and Nonobese Patients with Cardiovascular Indications.
Floroff CK; Palm NM; Steinberg DH; Powers ER; Wiggins BS
Pharmacotherapy; 2017 Apr; 37(4):393-400. PubMed ID: 28107569
[TBL] [Abstract][Full Text] [Related]
16. Persistent thrombin generation during heparin therapy in patients with acute coronary syndromes.
Merlini PA; Ardissino D; Bauer KA; Oltrona L; Pezzano A; Bottasso B; Rosenberg RD; Mannucci PM
Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1325-30. PubMed ID: 9261263
[TBL] [Abstract][Full Text] [Related]
17. Effect of Abciximab on prothrombin activation and thrombin generation in acute coronary syndromes without ST-segment elevation: Global Utilization of Strategies to Open Occluded Coronary Arteries Trial IV in Acute Coronary Syndromes (GUSTO IV ACS) Italian Hematologic Substudy.
Merlini PA; Repetto A; Lombardi A; Vetrano A; Fetiveau R; Cavallini C; Sappè D; Salvioni A; Canziani R; Savonitto S; Mannucci PM; Ardissino D
Circulation; 2002 Feb; 105(8):928-32. PubMed ID: 11864920
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulation for acute coronary syndromes: from heparin to direct thrombin inhibitors.
Lepor NE
Rev Cardiovasc Med; 2007; 8 Suppl 3():S9-17. PubMed ID: 17917621
[TBL] [Abstract][Full Text] [Related]
19. A low molecular weight, selective thrombin inhibitor, inogatran, vs heparin, in unstable coronary artery disease in 1209 patients. A double-blind, randomized, dose-finding study. Thrombin inhibition in Myocardial Ischaemia (TRIM) study group.
Eur Heart J; 1997 Sep; 18(9):1416-25. PubMed ID: 9458447
[TBL] [Abstract][Full Text] [Related]
20. A pilot study documenting increased thrombin generation following abrupt withdrawal of heparin therapy in healthy dogs.
Mays EM; Dorman DC; McKendry C; Hanel RM
J Vet Emerg Crit Care (San Antonio); 2018 Nov; 28(6):518-526. PubMed ID: 30303616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
